UroGen Pharma (URGN) Tops Q3 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| (NASDAQ: URGN) | Delayed: 33.48 -0.27 (0.8%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.75 | 52 Week High | $ | |||
| Open | $33.79 | 52 Week Low | $ | |||
| Day High | $34.94 | P/E | N/A | |||
| Day Low | $32.96 | EPS | $ | |||
| Volume | 1,424,445 | |||||
